{"id":"https://openalex.org/W198130339","doi":"https://doi.org/10.1016/b978-1-4832-8363-0.50150-6","title":"CONTROL OF \u03b2-ADRENERGIC RECEPTORS IN HELA CELLS","display_name":"CONTROL OF \u03b2-ADRENERGIC RECEPTORS IN HELA CELLS","publication_year":1979,"publication_date":"1979-01-01","ids":{"openalex":"https://openalex.org/W198130339","doi":"https://doi.org/10.1016/b978-1-4832-8363-0.50150-6","mag":"198130339"},"language":"en","primary_location":{"id":"doi:10.1016/b978-1-4832-8363-0.50150-6","doi":"https://doi.org/10.1016/b978-1-4832-8363-0.50150-6","is_oa":false,"landing_page_url":"https://doi.org/10.1016/b978-1-4832-8363-0.50150-6","pdf_url":null,"source":{"id":"https://openalex.org/S4306463230","display_name":"Elsevier eBooks","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"ebook platform"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Catecholamines: Basic and Clinical Frontiers","raw_type":"book-chapter"},"volume":{"id":"https://openalex.org/W4253763218","display_name":"Catecholamines: Basic and Clinical Frontiers"},"type":"book-chapter","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5110408780","display_name":"John F. Tallman","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210110767","display_name":"National Institute of Neurological Disorders and Stroke","ror":"https://ror.org/01s5ya894","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210110767"]},{"id":"https://openalex.org/I4210158500","display_name":"National Institute of Mental Health","ror":"https://ror.org/04xeg9z08","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210158500"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"John F. Tallman","raw_affiliation_strings":["National Institute of Mental Health and National Institut of Neurological and Communicative Disorders and Stroke, Bethesda, Maryland 20014, U.S.A"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National Institute of Mental Health and National Institut of Neurological and Communicative Disorders and Stroke, Bethesda, Maryland 20014, U.S.A","institution_ids":["https://openalex.org/I4210110767","https://openalex.org/I4210158500"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063084960","display_name":"Richard C. Henneberry","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210110767","display_name":"National Institute of Neurological Disorders and Stroke","ror":"https://ror.org/01s5ya894","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210110767"]},{"id":"https://openalex.org/I4210158500","display_name":"National Institute of Mental Health","ror":"https://ror.org/04xeg9z08","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210158500"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Richard C. Henneberry","raw_affiliation_strings":["National Institute of Mental Health and National Institut of Neurological and Communicative Disorders and Stroke, Bethesda, Maryland 20014, U.S.A"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National Institute of Mental Health and National Institut of Neurological and Communicative Disorders and Stroke, Bethesda, Maryland 20014, U.S.A","institution_ids":["https://openalex.org/I4210110767","https://openalex.org/I4210158500"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077865370","display_name":"Fusao Hirata","orcid":"https://orcid.org/0000-0002-7565-9139","observed_orcids":["https://orcid.org/0000-0002-7565-9139"]},"institutions":[{"id":"https://openalex.org/I4210110767","display_name":"National Institute of Neurological Disorders and Stroke","ror":"https://ror.org/01s5ya894","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210110767"]},{"id":"https://openalex.org/I4210158500","display_name":"National Institute of Mental Health","ror":"https://ror.org/04xeg9z08","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210158500"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Fusao Hirata","raw_affiliation_strings":["National Institute of Mental Health and National Institut of Neurological and Communicative Disorders and Stroke, Bethesda, Maryland 20014, U.S.A"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National Institute of Mental Health and National Institut of Neurological and Communicative Disorders and Stroke, Bethesda, Maryland 20014, U.S.A","institution_ids":["https://openalex.org/I4210110767","https://openalex.org/I4210158500"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5103384109","display_name":"Julius Axelrod","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210110767","display_name":"National Institute of Neurological Disorders and Stroke","ror":"https://ror.org/01s5ya894","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210110767"]},{"id":"https://openalex.org/I4210158500","display_name":"National Institute of Mental Health","ror":"https://ror.org/04xeg9z08","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210158500"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Julius Axelrod","raw_affiliation_strings":["National Institute of Mental Health and National Institut of Neurological and Communicative Disorders and Stroke, Bethesda, Maryland 20014, U.S.A"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National Institute of Mental Health and National Institut of Neurological and Communicative Disorders and Stroke, Bethesda, Maryland 20014, U.S.A","institution_ids":["https://openalex.org/I4210110767","https://openalex.org/I4210158500"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.7963,"has_fulltext":false,"cited_by_count":5,"citation_normalized_percentile":{"value":0.71409807,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":"489","last_page":"491"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11178","display_name":"Receptor Mechanisms and Signaling","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11178","display_name":"Receptor Mechanisms and Signaling","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10077","display_name":"Neuroscience and Neuropharmacology Research","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10169","display_name":"Protein Kinase Regulation and GTPase Signaling","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/beta-adrenergic-receptors","display_name":"beta-adrenergic receptors","score":0.972000002861023},{"id":"https://openalex.org/keywords/hela-cells","display_name":"HeLa cells","score":0.9829999804496765},{"id":"https://openalex.org/keywords/butyrate","display_name":"butyrate","score":0.984000027179718},{"id":"https://openalex.org/keywords/receptor-density","display_name":"receptor density","score":0.652999997138977},{"id":"https://openalex.org/keywords/adenylyl-cyclase-activation","display_name":"adenylate cyclase activation","score":0.9860000014305115},{"id":"https://openalex.org/keywords/phospholipid-methylation","display_name":"phospholipid methylation","score":0.9819999933242798},{"id":"https://openalex.org/keywords/phosphatidylcholine","display_name":"phosphatidylcholine","score":0.9950000047683716},{"id":"https://openalex.org/keywords/receptor-regulation","display_name":"receptor regulation","score":0.5370000004768372}],"concepts":[{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.7598121166229248},{"id":"https://openalex.org/C2780069284","wikidata":"https://www.wikidata.org/wiki/Q5198121","display_name":"Cyclase","level":3,"score":0.7462204694747925},{"id":"https://openalex.org/C180526460","wikidata":"https://www.wikidata.org/wiki/Q356240","display_name":"Adenylate kinase","level":3,"score":0.7417001128196716},{"id":"https://openalex.org/C40465926","wikidata":"https://www.wikidata.org/wiki/Q410568","display_name":"Adrenergic receptor","level":3,"score":0.6350947022438049},{"id":"https://openalex.org/C2777366897","wikidata":"https://www.wikidata.org/wiki/Q847482","display_name":"HeLa","level":3,"score":0.5989546775817871},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.45258718729019165},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.35542789101600647},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.3504140079021454},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.2682132124900818},{"id":"https://openalex.org/C1491633281","wikidata":"https://www.wikidata.org/wiki/Q7868","display_name":"Cell","level":2,"score":0.11569201946258545}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1016/b978-1-4832-8363-0.50150-6","doi":"https://doi.org/10.1016/b978-1-4832-8363-0.50150-6","is_oa":false,"landing_page_url":"https://doi.org/10.1016/b978-1-4832-8363-0.50150-6","pdf_url":null,"source":{"id":"https://openalex.org/S4306463230","display_name":"Elsevier eBooks","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"ebook platform"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Catecholamines: Basic and Clinical Frontiers","raw_type":"book-chapter"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.504800021648407}],"sustainable_development_goals_aurora":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":7,"referenced_works":["https://openalex.org/W1965253026","https://openalex.org/W2016489960","https://openalex.org/W2032260858","https://openalex.org/W2035692772","https://openalex.org/W2043937374","https://openalex.org/W2060520073","https://openalex.org/W3209951468"],"related_works":["https://openalex.org/W2032260858","https://openalex.org/W2043937374","https://openalex.org/W2016489960","https://openalex.org/W1536268728","https://openalex.org/W1984609050","https://openalex.org/W1963631769","https://openalex.org/W1978832055","https://openalex.org/W2150737889","https://openalex.org/W2022934425","https://openalex.org/W2401066793"],"abstract_inverted_index":null,"counts_by_year":[],"updated_date":"2026-10-10T09:11:00.788812","created_date":"2016-06-24T00:00:00"}